Thomas, Pascal <br/><br/>
Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  May 2002 
 - 191-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(01)00480-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Fever--chemically induced<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Platelet Count<br/>Thrombocytopenia--chemically induced<br/>Vomiting--chemically induced<br/>Gemcitabine